Publications by authors named "Safeya M Mousa"
Future Med Chem
November 2024
Article Synopsis
- * The new compounds were tested in the lab against various cancer cell lines and showed promising results, particularly compounds 8a and 8b, which had higher anticancer activity compared to the standard drug, erlotinib.
- * Compound 8a also showed effective inhibition of specific cancer-related proteins (EGFR and VEGFR-2), and additional computational studies provided insights into the compounds’ properties and how they might behave in the body.
